SARTORIS, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 5.161
EU - Europa 4.939
AS - Asia 3.197
SA - Sud America 527
AF - Africa 83
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.924
Nazione #
US - Stati Uniti d'America 5.054
RU - Federazione Russa 1.645
GB - Regno Unito 1.221
SG - Singapore 1.218
CN - Cina 1.013
IT - Italia 444
DE - Germania 419
BR - Brasile 408
VN - Vietnam 282
FI - Finlandia 280
HK - Hong Kong 248
SE - Svezia 235
FR - Francia 222
IE - Irlanda 194
KR - Corea 87
UA - Ucraina 79
BD - Bangladesh 62
CA - Canada 57
TR - Turchia 47
IN - India 46
AR - Argentina 43
NL - Olanda 42
ID - Indonesia 36
JP - Giappone 34
PL - Polonia 31
MX - Messico 28
ZA - Sudafrica 28
BE - Belgio 26
ES - Italia 25
IQ - Iraq 22
NG - Nigeria 21
PK - Pakistan 21
CO - Colombia 15
EC - Ecuador 15
VE - Venezuela 15
AT - Austria 14
PY - Paraguay 12
SA - Arabia Saudita 12
AU - Australia 11
IR - Iran 9
CL - Cile 8
CZ - Repubblica Ceca 7
IL - Israele 7
JO - Giordania 7
CH - Svizzera 6
LV - Lettonia 6
PE - Perù 6
UZ - Uzbekistan 6
EG - Egitto 5
LU - Lussemburgo 5
MY - Malesia 5
RO - Romania 5
SI - Slovenia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
EU - Europa 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
PA - Panama 4
PH - Filippine 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
BJ - Benin 3
ET - Etiopia 3
KE - Kenya 3
LB - Libano 3
NO - Norvegia 3
PT - Portogallo 3
TG - Togo 3
TT - Trinidad e Tobago 3
AG - Antigua e Barbuda 2
AM - Armenia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
NI - Nicaragua 2
OM - Oman 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
GM - Gambi 1
Totale 13.911
Città #
Southend 1.045
Singapore 654
Ashburn 616
Moscow 575
Jacksonville 510
Chandler 454
Dallas 421
San Jose 410
Woodbridge 387
Verona 264
Ann Arbor 247
Hong Kong 245
Dublin 187
Munich 167
Beijing 154
The Dalles 141
New York 128
Houston 116
Los Angeles 114
Helsinki 99
Council Bluffs 90
Jinan 81
Nanjing 80
Wilmington 79
Ho Chi Minh City 74
Lawrence 74
Princeton 74
Shenyang 73
Hanoi 58
Buffalo 51
Tianjin 48
Turku 48
Hebei 46
Haikou 41
Zhengzhou 39
São Paulo 37
Columbus 36
Santa Clara 36
Nanchang 32
Orem 32
Changsha 27
Dong Ket 27
Hangzhou 27
Brussels 26
Sindelfingen 26
Milan 25
Boardman 24
Ningbo 24
Tokyo 24
London 23
Redmond 23
Johannesburg 22
Montreal 22
Taiyuan 22
Jakarta 21
Redwood City 21
Abuja 20
Guangzhou 20
Taizhou 20
Warsaw 20
Amsterdam 19
Atlanta 19
Denver 19
Frankfurt am Main 19
Chicago 17
Seoul 17
Stockholm 17
Toronto 17
Seattle 16
Brooklyn 15
Chennai 15
Da Nang 14
Düsseldorf 14
Nürnberg 13
Belo Horizonte 12
Cambridge 12
Jiaxing 12
Lancaster 12
Manchester 12
San Francisco 12
Ankara 11
Falls Church 11
Lanzhou 11
Fairfield 10
Fuzhou 10
Madrid 10
Poplar 10
Redondo Beach 10
City of London 9
Curitiba 9
Istanbul 9
Mumbai 9
Norwalk 9
Phoenix 9
Querétaro 9
Baghdad 8
Boston 8
Dearborn 8
Kent 8
Nuremberg 8
Totale 9.016
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 312
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 311
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 295
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 294
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 286
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 282
Cell contact-dependent PMN HLA-DR and CD69 membrane expression induced by autologous mono-lymphocytes and cell lines. 268
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 267
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 260
A novel cell line and xenograft model of ampulla of Vater adenocarcinoma 244
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 241
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 232
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 230
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 229
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 228
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 226
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 224
Induction and expansion of an anti-tumor immune response by B7-1+ tumor cells in dependence on the anatomical site of delivery and the dose applied 223
Autologous cellular vaccine allows control of cancer immunoediting in a mouse model of plasmacytoma. 223
Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability 218
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 216
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 212
A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes. 207
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 196
A non-parametric method for the analysis of experimental tumour growth data 195
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 195
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. 190
Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response 188
Alternative splicing of HLA-DQB transcripts and secretion of HLA-DQ beta-chain proteins: allelic polymorphism in splicing and polyadenylylation sites 187
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 186
Bone marrow-, spleen- and thymus-derived mesenchymal stem cells favour the growth of myeloma cells in a mouse model 181
Effects of dietary wheat germ deprivation on the immune system in wistars rats: a pilot study 177
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression. 176
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 176
A rapid and improved method for generating cDNA libraries in plasmid and phage vectors 175
Distinct regulation of HLA class II and class I cell surface expression in the THP-1 macrophage cell line after bacterial phagocytosis 171
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
Immune regulation by Mesenchymal Stem Cells derived from adult spleen and thymus. 170
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of Major Histocompatibility Complex class II gene expression observed during differentiation from B cells to plasma cells. 169
Constitutive and inducible expression of HLA class II genes in normal cells is under the control of the AIR-1-encoded CIITa trans-activator 168
A rapid and improved method for generating cDNA libraries in plasmid and phage lambda vectors 168
The Endless Saga of Monocyte Diversity 165
CONSTITUTIVE AND INDUCIBLE EXPRESSION OF HLA CLASS II GENES IN NORMAL CELLS UNDER THE CONTROL OF THE AIR-1-ENCODED CIITA TRANS-ACTIVATOR 161
HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA. Acquisition of antigen processing and presentation capacity. 160
Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen. 160
Local ablation disrupts immune evasion in pancreatic cancer 158
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 157
Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls. 155
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 152
Mitochondrial DNA polymorphism analyzed by restriction endonucleases in two sardinian populations 148
The Engagement Between MDSCs and Metastases: Partners in Crime 147
Functional significance of polymorphism among MHC class II gene promoters. 143
Structure and regulation of MHC system 142
Divergent evolution in the mechanisms controlling MHC class II gene transcription in mouse and human. 140
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 140
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones 140
Expression of HLA antigens in human pancreatic carcinomas 137
SEQUENCE POLYMORPHISM OF HLA-DP b CHAINS 134
HLA-DBQ1 typing of north east italian IDDM patients using amplified DNA oligonucleotide probes and a rapid DNA-enzyme immunoassay(DEIA). 133
Myelin basic protein epitopes secreted by human T cells encounter natural autoantibodies in the serum 133
Evidence for a specific post-transcriptional mechanisms controlling the expression of HLA-DQ, but not -DR and -DP, molecules. 130
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 127
Staphylococcal enterotoxin-dependent lysis of MHC class II negative target cells by cytolytic T lymphocytes 127
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 126
Regulation of CD5 gene expression in interspecies human x mouse T cell hybrids 126
Organization, polymorphism and regulation of class II genes of the major histocompatibility complex. 124
Mitochondrial DNA polymorphism in four Sardinian villages 122
Polimorfismo genetico mitocondriale in popolazioni sarde esposte a differente pressione selettiva malarica 121
Transcriptional regulation of MHC class II genes 119
Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours. 118
HLA-DQB1 typing of north east Italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-enzyme immunoassay (DEIA) 116
Oscillating growth patterns of multicellular tumour spheroids 115
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 114
Moonlighting Proteins Are Important Players in Cancer Immunology 110
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle 107
MHC: AN INTEGRATED GENETIC SYSTEM WHICH ORCHESTRATES THE IMMUNE RESPONSE. 106
Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules 105
Study of the optimal conditions for obtaining fusion complexes to be used as broad spectrum anti HIV-1 vaccine 99
Exploring the HLA complex in autoimmunity: from the risk haplotypes to the modulation of expression 86
MHC: orchestrating the immune response 77
null 33
Totale 14.080
Categoria #
all - tutte 43.785
article - articoli 33.685
book - libri 0
conference - conferenze 8.751
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.349
Totale 87.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 0 0 58
2021/2022709 73 223 6 34 26 18 30 41 37 28 60 133
2022/20231.320 89 154 135 237 122 282 11 82 150 7 26 25
2023/2024644 14 42 47 102 63 110 30 48 2 40 96 50
2024/20252.045 92 113 76 273 103 85 164 133 329 106 183 388
2025/20265.643 377 353 399 975 1.415 347 534 284 426 330 122 81
Totale 14.080